Pacific Biosciences of California (STU:P09) Interest Expense : €-13.1 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pacific Biosciences of California's interest expense for the three months ended in Mar. 2024 was € -3.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-13.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pacific Biosciences of California's Operating Income for the three months ended in Mar. 2024 was € -74.9 Mil. Pacific Biosciences of California's Interest Expense for the three months ended in Mar. 2024 was € -3.3 Mil. Pacific Biosciences of California did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pacific Biosciences of California Interest Expense Historical Data

The historical data trend for Pacific Biosciences of California's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Interest Expense Chart

Pacific Biosciences of California Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-2.35

-0.22

-11.09

-13.87

-13.15

Pacific Biosciences of California Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-3.39	-3.14	-3.36	-3.28	-3.29

Pacific Biosciences of California Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-13.1 Mil.

Pacific Biosciences of California (STU:P09) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pacific Biosciences of California's Interest Expense for the three months ended in Mar. 2024 was €-3.3 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-74.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €847.9 Mil.

Pacific Biosciences of California's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Pacific Biosciences of California did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Pacific Biosciences of California (STU:P09) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PACB:USA

Address

1305 O’Brien Drive, Menlo Park, CA, USA, 94025

Website

https://www.pacb.com

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California (STU:P09) Headlines

No Headlines